Clinical trial
Randomised Controlled Trial of Adjuvant Photodynamic Therapy to Reduce Restenosis After Percutaneous Transluminal Angioplasty to the Superficial Femoral Angioplasty
NCT00187811 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Controlled Trial of Adjuvant Photodynamic Therapy to Reduce Restenosis After Percutaneous Transluminal Angioplasty to the Superficial Femoral Angioplasty
- Lead sponsor
- University College London Hospitals
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- February 28, 2001
- Completion date
- June 30, 2006
- Enrollment
- 120
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic narrowing of the superficial femoral artery, atherosclerotic occlusion of the superficial femoral artery